CCE Stock UPDATES Coca-Cola Enterprises (CCE) 43.00 10/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Coca-Cola Enterprises (CCE) 43.00 $CCE

Third Quarter Earnings - Research Reports on Carter's, Skechers, Dana, Coca-Cola and Autoliv
PR Newswire - Tue Oct 28, 8:15AM CDT
Today, Analysts Review released its research reports regarding Carter's, Inc. (NYSE: CRI), Skechers USA Inc. (NYSE: SKX), Dana Holding Corporation (NYSE: DAN), Coca-Cola Enterprises Inc. (NYSE: CCE) and Autoliv, Inc. (NYSE: ALV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7493-100free.
ALV: 90.39 (-1.46), SKX: 54.15 (+0.07), DAN: 19.72 (-0.30), CRI: 78.24 (+0.12), CCE: 43.00 (-0.31)

Coca-Cola Enterprises Beats Earnings; Lowers Sales View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:10AM CDT
Coca-Cola Enterprises Inc. (CCE) announced dismal third-quarter 2014 earnings.
KO: 40.96 (+0.40), MNST: 98.65 (+1.20), GMCR: 147.87 (+1.21), CCE: 43.00 (-0.31)

Shares of CCE Down 7.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 23, 9:54AM CDT
SmarTrend identified a Downtrend for Coca-Cola Enterprises (NYSE:CCE) on September 5th, 2014 at $46.60. In approximately 2 months, Coca-Cola Enterprises has returned 7.64% as of today's recent price of $43.04.
CCE: 43.00 (-0.31)

Coca-Cola Enterprises tops 3Q earnings expectations
Automated Insights - Thu Oct 23, 7:01AM CDT
ATLANTA (AP) _ Coca-Cola Enterprises Inc. (CCE) on Thursday reported third-quarter net income of $238 million.
CCE: 43.00 (-0.31)

Coca-Cola Enterprises, Inc. Reports Third-Quarter 2014 Results and Full-Year Earnings Outlook
Business Wire - Thu Oct 23, 6:32AM CDT
--Net sales totaled $2.1 billion, down 11/2 percent on a reported basis, or down 31/2 percent on a currency-neutral basis; volume declined 4 percent.
CCE: 43.00 (-0.31)

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
AVD: 10.85 (-0.04), CVCY: 10.78 (unch), CCE: 43.00 (-0.31), AIR: 25.43 (-0.06), GTLS: 46.29 (-0.88)

Coca-Cola Enterprises, Inc. Declares Regular Quarterly Dividend
Business Wire - Mon Oct 20, 3:05PM CDT
The Coca-Cola Enterprises (NYSE: CCE)(Euronext Paris: CCE) Board of Directors declared a regular quarterly dividend of 25 cents per share. The dividend is payable December 4, 2014 to shareowners of record on November 21, 2014.
CCE: 43.00 (-0.31)

Can Coca-Cola Enterprises (CCE) Surprise Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 1:20PM CDT
Coca-Cola Enterprises Inc. (CCE) is set to report the third-quarter fiscal 2014 results on Oct 23, before the market opens.
WWAV: 36.95 (+0.02), KO: 40.96 (+0.40), HSY: 94.06 (-1.47), CCE: 43.00 (-0.31)

Coca-Cola Enterprises Down 14.8% Since SmarTrend Downtrend Call (CCE)
Comtex SmarTrend(R) - Thu Oct 16, 9:34AM CDT
SmarTrend identified a Downtrend for Coca-Cola Enterprises (NYSE:CCE) on September 5th, 2014 at $46.60. In approximately 1 month, Coca-Cola Enterprises has returned 14.79% as of today's recent price of $39.71.
CCE: 43.00 (-0.31)

Zacks Industry Outlook Highlights: Unilever, Coca-Cola Enterprises, Kimberly-Clark, PepsiCo and Procter & Gamble
PR Newswire - Wed Oct 15, 8:30AM CDT
Today, Zacks Equity Research discusses the Consumer Staples (part 3), including Unilever plc (NYSE:UL-Free Report), Coca-Cola Enterprises, Inc. (NYSE:CCE-Free Report), Kimberly-Clark Corp. (NYSE:KMB-Free Report), PepsiCo Inc. (NYSE EP-Free Report) and Procter & Gamble Co. (NYSE G-Free Report).
KMB: 113.44 (-0.29), UL: 39.85 (-0.11), CCE: 43.00 (-0.31), PEP: 94.69 (-0.57)

Macroeconomic Factors Weigh on Consumer Staples Stocks - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 3:39AM CDT
Macroeconomic Factors Weigh on Consumer Staples Stocks - Zacks Analyst Interviews
DPS: 67.72 (-0.18), KO: 40.96 (+0.40), MDLZ: 34.93 (-0.36), KMB: 113.44 (-0.29), TAP: 72.90 (-0.70), PG: 86.54 (+0.07), UL: 39.85 (-0.11), CCE: 43.00 (-0.31), DEO: 116.28 (+0.24), K: 62.47 (-0.28), PEP: 94.69 (-0.57)

Macroeconomic Factors Weigh on Consumer Staples Stocks - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 3:39AM CDT
Macroeconomic Factors Weigh on Consumer Staples Stocks - Industry Outlook
DPS: 67.72 (-0.18), KO: 40.96 (+0.40), MDLZ: 34.93 (-0.36), KMB: 113.44 (-0.29), TAP: 72.90 (-0.70), PG: 86.54 (+0.07), UL: 39.85 (-0.11), CCE: 43.00 (-0.31), DEO: 116.28 (+0.24), K: 62.47 (-0.28), PEP: 94.69 (-0.57)

Are Cost-Control Measures Driving Consumer Staples? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 3:37AM CDT
Are Cost-Control Measures Driving Consumer Staples? - Industry Outlook
MDLZ: 34.93 (-0.36), MKC: 69.32 (-0.45), GMCR: 147.87 (+1.21), KMB: 113.44 (-0.29), SYY: 38.21 (+0.01), LO: 61.22 (+0.19), KRFT: 56.91 (-0.34), CCE: 43.00 (-0.31), SJM: 102.52 (-1.39), PEP: 94.69 (-0.57), K: 62.47 (-0.28), DPS: 67.72 (-0.18), SBUX: 76.54 (-0.51), DNKN: 45.75 (-0.63), RAI: 62.22 (+0.20), KO: 40.96 (+0.40), BUD: 109.92 (-0.27), UN: 38.13 (-0.10), TAP: 72.90 (-0.70), TSN: 38.96 (-0.40), UL: 39.85 (-0.11), MO: 47.57 (+0.04), WWAV: 36.95 (+0.02), PM: 87.91 (-0.36), UNFI: 66.15 (+0.39), BGS: 28.69 (+0.24), PG: 86.54 (+0.07), GIS: 50.90 (-0.48)

How Will Coca-Cola Enterprises (CCE) Stock Be Affected Today by This Analyst Action?
at The Street - Mon Oct 06, 7:32AM CDT
Nomura Group upgraded Coca-Cola Enterprises (CCE) to 'neutral' from 'reduce' with a price target of $134.
CCE: 43.00 (-0.31)

Upgrade Alert for Coca-Cola Enterprises (CCE)
Comtex SmarTrend(R) - Mon Oct 06, 6:57AM CDT
Coca-Cola Enterprises (NYSE:CCE) was upgraded from Reduce to Neutral at Nomura today. The stock closed yesterday at $44.08 on volume of 3.2 million shares, above average daily volume of 1.8 million. Coca-Cola Enterprises (NYSE:CCE) has potential upside of 14.6% based on a current price of $44.08 and analysts' consensus price target of $50.53. Coca-Cola Enterprises shares should first meet resistance at the 200-day moving average (MA) of $46.04 and find additional resistance at the 50-day MA of $46.25.
CCE: 43.00 (-0.31)

Coca-Cola Enterprises, Inc. to Webcast Third-Quarter 2014 Earnings Conference Call
Business Wire - Thu Sep 25, 8:00AM CDT
Coca-Cola Enterprises (NYSE: CCE) (Euronext Paris: CCE) will release third-quarter 2014 earnings before the market opens on Thursday, October 23.
CCE: 43.00 (-0.31)

Look for Shares of Coca-Cola Enterprises to Potentially Rebound after Yesterday's 2.30% Sell Off
Comtex SmarTrend(R) - Tue Sep 23, 5:21PM CDT
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $45.03 to a high of $45.92. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $45.67 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CCE: 43.00 (-0.31)

Coca-Cola Enterprises Falls 2.30% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 23, 5:20PM CDT
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $45.03 to a high of $45.92. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $45.67 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CCE: 43.00 (-0.31)

SmarTrend Watching for Potential Pullback in Shares of Coca-Cola Enterprises After 1.20% Gain
Comtex SmarTrend(R) - Fri Sep 19, 4:18PM CDT
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $45.78 to a high of $46.38. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $46.25 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.00 (-0.31)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading